Jiangsu Chinagreen Biological Technology Group Co., Ltd.

SZSE:300970 Stock Report

Market Cap: CN¥1.5b

Jiangsu Chinagreen Biological Technology Group Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Jiangsu Chinagreen Biological Technology Group.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Food earnings growth22.3%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Jiangsu Chinagreen Biological TechnologyLtd (SZSE:300970) Is Due To Pay A Dividend Of CN¥0.20

May 31
Jiangsu Chinagreen Biological TechnologyLtd (SZSE:300970) Is Due To Pay A Dividend Of CN¥0.20

Market Might Still Lack Some Conviction On Jiangsu Chinagreen Biological Technology Co.,Ltd. (SZSE:300970) Even After 39% Share Price Boost

May 21
Market Might Still Lack Some Conviction On Jiangsu Chinagreen Biological Technology Co.,Ltd. (SZSE:300970) Even After 39% Share Price Boost

Jiangsu Chinagreen Biological TechnologyLtd (SZSE:300970) Will Want To Turn Around Its Return Trends

Apr 18
Jiangsu Chinagreen Biological TechnologyLtd (SZSE:300970) Will Want To Turn Around Its Return Trends

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Jiangsu Chinagreen Biological Technology Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SZSE:300970 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/2024981-81-16399N/A
6/30/2024930-122-17068N/A
3/31/2024921-98-14860N/A
12/31/202399630-57167N/A
9/30/202397587-113188N/A
6/30/2023985185-56304N/A
3/31/2023913182-117268N/A
1/1/202375278-228180N/A
9/30/202272487-126213N/A
6/30/202263116-19096N/A
3/31/202261011-116128N/A
12/31/202157816-12183N/A
9/30/202155027-16070N/A
6/30/202156461-13198N/A
3/31/202157091-94128N/A
12/31/20206091338199N/A
12/31/2019575121115214N/A
12/31/201839456-129100N/A
12/31/201734864N/A113N/A
6/30/201730263N/A145N/A
3/31/201728463N/A123N/A
12/31/201626660N/A89N/A
9/30/201625757N/A109N/A
6/30/201624759N/A121N/A
3/31/201624457N/A107N/A
12/31/201524152N/A97N/A
9/30/201523050N/A75N/A
6/30/201522047N/A58N/A
3/31/201520742N/A65N/A
12/31/201419232N/A69N/A
12/31/201315020N/A36N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 300970's forecast earnings growth is above the savings rate (2.8%).

Earnings vs Market: Insufficient data to determine if 300970's earnings are forecast to grow faster than the CN market

High Growth Earnings: Insufficient data to determine if 300970's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 300970's revenue is forecast to grow faster than the CN market.

High Growth Revenue: Insufficient data to determine if 300970's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 300970's Return on Equity is forecast to be high in 3 years time


Discover growth companies